EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol

Mohsin Kazi iD, Athba Alqahtani, Majed Alharbi, Ajaz Ahmad, Muhammad Delwar Hussain, Hani Alothaid iD, Mohammed S Aldughaim

Molecules · 2023

DOI: 10.3390/molecules28031492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Mohsin Kazi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Sau…. Hauptthemen laut MEDLINE: Propofol, Nanoparticles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Fahad Medical City, research center, Kingdom of Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Propofol is a relatively short-acting potent anesthetic lipophilic drug used during short surgical procedures. Despite the success of propofol intravenous emulsions, drawbacks to such formulations include inherent emulsion instability, the lack of a safe vehicle to prevent sepsis, and concern regarding hyperlipidemia-related side effects. The aim of the current investigation was to develop a novel, lipid-based self-nanoemulsifying drug delivery system (SNEDDS) for propofol with improved stability and anesthetic activity for human use.

Methods

A series of SNEDDS formulations were developed using naturally obtained medium-chain/long-chain mono-, di-, and triglycerides, glyceryl monocaprylate, and water-soluble cosolvents with hydrogenated castor oil constructing ternary phase diagrams for propofol. The developed SNEDDS formulations were characterized using visual observation, particle size analysis, zeta potential, transmission electron microscopy, equilibrium solubility, in vitro dynamic dispersion and stability, and in vivo sleeping disorder studies in rats. The in vivo bioavailability of the SNEDDSs in rats was also studied to compare the representative formulations with the marketed product Diprivan®.

Results

Medium-chain triglycerides (M810) with mono-diglycerides (CMCM) as an oil blend and hydrogenated castor oil (KHS15) as a surfactant were selected as key ingredients in ternary phase diagram studies. The nanoemulsifying regions were identified from the studies and a number of SNEDDSs were formulated. Results from the characterization studies demonstrated the formation of efficient nanosized particles (28–45 nm globule size, 0.10–0.20 PDI) in the optimized SNEDDS with a drug loading of 50 mg/g, which is almost 500-fold higher than free propofol. TEM analysis showed the formation of spherical and homogeneous nanoparticles of less than 50 nm. The dissolution rate of the representative SNEDDS was faster than raw propofol and able to maintain 99% propofol in aqueous solution for around 24 h. The optimized liquid SNEDDS formulation was found to be thermodynamically stable. The intravenous administration of the SNEDDS in male Wistar rats induced a sleeping time of 73–88 min. The mean plasma concentrations after the IV administration of propofol nano-formulations PF2-SNEDDS and PF8-SNEDDS were 1348.07 ± 27.31 and 1138.66 ± 44.97 µg/mL, as compared to 891.44 ± 26.05 µg/mL (p = 0.05) observed after the IV administration of raw propofol.

Conclusion

Propofol-loaded SNEDDS formulations could be a potential pharmaceutical product with improved stability, bioavailability, and anesthetic activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropofolNanoparticlesRatsMaleHumansAnimalsRats, WistarCastor OilDrug Delivery SystemsSolubilityEmulsionsBiological AvailabilityTriglyceridesAdministration, IntravenousParticle SizeAdministration, OralDrug Liberation

Stichwörter der Autor:innen

intravenous deliverypharmacokineticspropofolself-nanoemulsifying drug delivery systemssleeping disorder

Substanzen

PropofolCastor OilEmulsionsTriglycerides

Autor:innen und Institutionen

  • Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Research Center, King Fahad Medical City, Riyadh 11451, Saudi Arabia.
  • Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Pharmacy, Husson University, Bangor, ME 04401, USA.
  • Department of Basic Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al Baha 65528, Saudi Arabia.

ORCID-Profile: Mohsin Kazi, Hani Alothaid

Förderung

  • King Fahad Medical City, research center, Kingdom of Saudi Arabia

Zitieren

APA

Kazi, M., Alqahtani, A., Alharbi, M., Ahmad, A., Hussain, M. D., Alothaid, H., & Aldughaim, M. S. (2023). The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol. Molecules. https://doi.org/10.3390/molecules28031492

Vancouver

Kazi M, Alqahtani A, Alharbi M, Ahmad A, Hussain MD, Alothaid H, et al. The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol. Molecules. 2023. doi:10.3390/molecules28031492

BibTeX
@article{Kazi2023,
  author = {Kazi, Mohsin and Alqahtani, Athba and Alharbi, Majed and Ahmad, Ajaz and Hussain, Muhammad Delwar and Alothaid, Hani and Aldughaim, Mohammed S},
  title = {The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28031492}
}
Kostenlos starten →